MARKET

AXDX

AXDX

Accelerate
NASDAQ

Real-time Quotes | Nasdaq Last Sale

15.86
-1.26
-7.36%
After Hours: 16.00 +0.14 +0.88% 19:22 07/02 EDT
OPEN
17.51
PREV CLOSE
17.12
HIGH
18.54
LOW
15.12
VOLUME
1.04M
TURNOVER
--
52 WEEK HIGH
24.00
52 WEEK LOW
4.530
MARKET CAP
876.59M
P/E (TTM)
-10.3282
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AXDX stock price target is 13.50 with a high estimate of 14.00 and a low estimate of 13.00.

EPS

AXDX News

More
Accelerate Diagnostics Inc (AXDX): Hedge Funds Are Snapping Up
Insider Monkey · 06/25 23:26
Accelerate Diagnostics Option Alert: Jul 17 $10 Calls Sweep (14) near the Ask: 435 @ $2.5 vs 220 OI; Earnings 8/6 After Close [est] Ref=$12.0
Benzinga · 06/22 19:02
Insider Weekends: Charles Davis Purchases $56 Million Worth Of AXIS Capital
Seeking Alpha - Article · 06/22 11:06
Faruqi & Faruqi, LLP is Investigating Accelerate Diagnostics, Inc. (AXDX) on Behalf of its Shareholders
GlobeNewswire · 06/15 14:20
Insider Weekends: Director Of Accelerate Diagnostics Adds To His Stock
Seeking Alpha - Article · 06/15 13:20
Accelerate Diagnostics (AXDX) Moves to Strong Buy: Rationale Behind the Upgrade
Zacks · 05/29 17:00
How Accelerate Diagnostics (AXDX) Stock Stands Out in a Strong Industry
Accelerate Diagnostics (AXDX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Zacks · 05/26 12:51
Edited Transcript of AXDX earnings conference call or presentation 7-May-20 8:30pm GMT
Thomson Reuters StreetEvents · 05/21 21:06

Industry

Advanced Medical Equipment & Technology
+1.07%
Healthcare Equipment & Supplies
+0.92%

Hot Stocks

Symbol
Price
%Change

About AXDX

Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. It detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate PhenoTest BC Kit provides ID and AST results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit.
More

Webull offers kinds of Accelerate Diagnostics Inc stock information, including NASDAQ:AXDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXDX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AXDX stock methods without spending real money on the virtual paper trading platform.